For the Inventor, By the Inventor

Enter assignee name

Worcester, MA, United States of America

Advanced Cell Technology, Inc.

USPTO Granted Patents = 21

% Expired Patents = 28.6

CIPO Patents = 3

EPO Patents = 2

Forward Citations = 322

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Robert P Lanza (12 out of 59 patents)

Irina V Klimanskaya (8 out of 25 patents)

Michael D West (7 out of 46 patents)

4. Young Gie Chung (5 out of 13 patents)

5. Jose Cibelli (4 out of 13 patents)

6. Karen B Chapman (4 out of 33 patents)

7. Shi-Jiang Lu (2 out of 23 patents)

8. Raymond L Page (2 out of 3 patents)

9. Amy Burnside (2 out of 3 patents)

10. James M Robl (2 out of 24 patents)

11. Qiang Feng (1 out of 10 patents)

12. Hans R Schoeler (1 out of 2 patents)

13. Christopher Malcuit (1 out of 3 patents)

14. Tanja Dominko (1 out of 5 patents)

15. Hans Scholer (1 patent)

21 patents: Sort by Forward Citations

1. 12653840 - METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF (2026-06-16),

2. 10047340 - Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank (2018-08-14),

3. 9580683 - ES cell cytoplasm or ooplasm transfer to rejuventate recipient cells (2017-02-28),

4. 9334478 - Differentiating ES cells using a tenascin (2016-05-10),

5. 8796021 - Blastomere culture to produce mammalian embryonic stem cells (2014-08-05),

6. 8753884 - Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells (2014-06-17),

7. 8742200 - Derivation of embryonic stem cells and embryo-derived cells (2014-06-03),

8. 8642328 - Derivation of embryonic stem cells (2014-02-04),

9. 8597944 - Culture systems for ex vivo development (2013-12-03),

10. 8273571 - Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues (2012-09-25),

11. 8268303 - Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration (2012-09-18),

12. 8017393 - Hemangio-colony forming cells (2011-09-13),

13. 7951591 - Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues (2011-05-31),

14. 7910369 - Culture systems for ex vivo development (2011-03-22),

15. 7893315 - Derivation of embryonic stem cells and embryo-derived cells (2011-02-22),

Advanced Cell Technology, Inc. is a biotechnology company based in Worcester, Massachusetts, specializing in regenerative medicine and cell therapy. The organization focuses on developing innovative treatments for various degenerative diseases through the use of stem cell technology. Its research encompasses areas such as ocular diseases and other conditions that impact quality of life, aiming to harness the potential of stem cells to repair and regenerate damaged tissues. Advanced Cell Technology is committed to advancing scientific knowledge and therapeutic options in the field of regenerative medicine.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

21 Patents

#17 in Worcester, MA

#942 in Massachusetts

#15,668 in US

#29,893 in the World

Worcester, MA, United States of America

Advanced Cell Technology, Inc.

Forward Citations = 322

14 inventors:

Robert P Lanza (12 out of 59 patents)

Irina V Klimanskaya (8 out of 25 patents)

Michael D West (7 out of 46 patents)

4. Young Gie Chung (5 out of 13 patents)

5. Jose Cibelli (4 out of 13 patents)

Please report any incorrect information to [email protected]

Loading…